The CXXC Zn binding motifs of the human papillomavirus type 16 E7 oncoprotein are not required for its in vitro transforming activity in rodent cells

Oncogene

Volumn 16, Issue 8, 1998, Pages 1085-1089

  Braspenning, Joris ^a   Marchini, Antonio ^a   Albarani, Valentina ^a   Levy, Laura ^b   Ciccolini, Francesca ^a   Cremonesi, Caterina ^a   Ralston, Robert ^c   Gissmann, Lutz ^a   Tommasino, Massimo ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b NOVARTIS PHARMA AG   (Switzerland)

^c GeneMedicine Inc   (United States)

Author keywords

Cellular transformation; CXXC motifs; E7 homodimerization; E7 E1A243 chimeric protein; Human papillomavirus type 16 E7 protein

Indexed keywords

ONCOPROTEIN; VIRUS PROTEIN; ZINC;

ANIMAL CELL; CELL STRAIN 3T3; EMBRYO; FIBROBLAST; GENETIC CONSERVATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; RNA SPLICING; SACCHAROMYCES CEREVISIAE; SHORT SURVEY; STRUCTURE ACTIVITY RELATION; VIRUS CELL TRANSFORMATION; VIRUS ONCOGENE; WART VIRUS;

ADENOVIRIDAE; ANIMALIA; DNA VIRUSES; HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPES; PAPILLOMAVIRUS; RODENTIA; SACCHAROMYCES CEREVISIAE;

EID: 0032567955     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1201617     Document Type: Short Survey

References (26)

1. Barbosa MS, Lowy DR and Schiller JT. (1989). J. Virol., 63, 1404-1407.
2. Choo KB, Pan CC and Han SH. (1987). Virology, 161, 259-261.
3. Clemens KE, Brent R, Gyuris J and Munger K. (1995). Virology, 214, 289-293.
4. Cullen AP, Reid R, Csmpion M and Lorincz AT. (1991). J. Virol., 65, 606-612.
5. Davies R, Hicks R, Crook T, Morris J and Vousden K. (1993). J. Virol., 67, 2521-2528.
6. Dyson N, Howley PM, Munger K and Harlow E. (1989). Science, 243, 934-937.
7. Fattaey AR, Harlow E and Helin K. (1993). Mol. Cell. Biol., 13, 7267-7277.
8. Hu TH, Ferril SC, Snider AM and Barbosa MS. (1995). Int. J. Oncol., 6, 167-174.
9. Harlow E, Franza BR and Schley C. (1985). J. Virol., 55, 533-546.
10. Huang PS, Patrick DR, Edwards G, Goodhart PJ, Huber HE, Miles L, Garsky VM, Oliff A and Heimbrook DC. (1993). Mol. Cell. Biol., 13, 953-960.
11. Ikeda MA and Nevins JR. (1993). Molecular and Cellular Biology, 13, 7029-7035.
12. Kouzarides T. (1995). Semin. Cancer Biol., 6, 91-98.
13. Laemmli UK. (1970). Nature, 227, 680-685.
14. Mansur CP and Androphy EJ. (1993). Biochim. Biophys. Acta, 1155, 323-345.
15. McIntyre MC, Frattini MG, Grossman SR and Laimins LA. (1993). J. Virol., 67, 3142-3150.
16. Patrick DR, Oliff A and Heimbrook DC. (1994). J. Biol. Chem., 269, 6842-6850.
17. Phelps WC, Yee CL, Münger K and Howley PM. (1988). Cell, 53, 539-547.
18. Schwarz E, Freese UK, Gissmann L, Mayer W, Roggenbuck B, Stremlau A and zur Hausen H. (1985). Nature, 314, 111-114.
19. Tommasino M and Crawford L. (1995). Bioessays, 17, 509-518.
20. Vousden KH and Jat PS. (1989). Oncogene, 4, 153-158.
21. Whyte P, Ruley HE and Harlow E. (1988). J. Virol., 62, 257-265.
22. Whyte P, Williamson NM and Harlow E. (1989). Cell, 56, 67-75.
23. Wu EW, Clemens KE, Heck DV and Munger K. (1993). J. Virol., 67, 2402-2407.
24. Zerfass K, Levy L, Cremonesi C, Ciccolini F, Jansen-Dürr P, Crawford L, Ralston R and Tommasino M. (1995). J. Gen. Virol., 76, 1815-1820.
25. Zur Hausen H. (1991). Virology, 184, 9-13.
26. Zwerschke W, Joswig S and Jansen-Dürr P. (1996). Oncogene, 12, 213-220.